Third Major Vaccine Candidate Starting Phase 3 Trial In U.S.

AstraZeneca's COVID-19 vaccine, developed with Oxford University, has entered phase three trials in the US, involving up to 30,000 participants. This trial is similar in scale to those of Moderna and Pfizer, which began in July.

What new insight or understanding did you gain from this video?